WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Hong Kong welcomes joyful, bustling Spring FestivalYuan wins Chinese derby to progress at Indian WellsTax Day 2024: Here's what to do if you can't pay your taxes by the deadlineOklahoma family whose pet octopus laid FIFTY eggs reveals how they're looking after the consortiumDisneyland rides on its swift successesChina's Dunhuang, French museum to coApple CEO says that he wants to increase investments in VietnamSancho, Reus send Dortmund to UCL quartersNorth China's Inner Mongolia launches ancient books database platformDisneyland rides on its swift successes